Illness	Number of cases
Mental and behavioural disorders due to use of alcohol (F10.2)	596
Mental and behavioural disorders due to use of opioids (F11.2)	116
Mental and behavioural disorders due to use of cannabinoids (F12.2)	111
Borderline personality disorder (F60.31)	97
Mental and behavioural disorders due to use of sedatives or hypnotics (F13.2)	81
Recurrent depressive disorder - Major depressive disorder recurrent moderate (F33.1)	57
Mental and behavioural disorders due to use of cocaine (F14.2)	56
Mental and behavioural disorders due to use of other stimulants including caffeine (F15.2)	36
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances (F19.2)	36
Schizophrenia - Paranoid schizophrenia (F20.0)	35

Top 10 treatments

Treatment	Number
Standard treatment for mental and psychosomatic disorders and behavioral disorders in adults (9-607)	1.773
(9-649.40)	1.746
(9-649.0)	1.374
(9-649.20)	842
(9-649.10)	608
(9-649.31)	452
Complex psychotherapeutic treatment for mental and psychosomatic disorders and behavioral disorders in adults (9-626)	401
(9-649.11)	211
(9-649.41)	206
(9-649.50)	162

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2900 , 2970 , 2971 , 2972

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01
CQ28

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
82	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
53	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
53	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Participation in multi-centre Phase I/II studies
Lectureships / teaching posts at universities of applied sciences
Lectureships / teaching posts at colleges and universities
Student training (clinical traineeship / internship year)
Editors of scientific journals/textbooks
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Project-related cooperation with colleges and universities
Doctoral supervision
Participation in multi-centre phase III/IV studies

Training

No.	Training in other healing professions	Comment
HB07	Surgical technical assistant (m/f)
HB01	Nurse and health care worker (m/f)
HB19	Nursing professionals
HB15	Anaesthesia technical assistant (m/f)
HB05	Medical technical radiology assistant (MTRA) (m/f)